Innovation to Drive Growth in Central Nervous System Therapeutics Market by 2034
The Central Nervous System (CNS) Therapeutics market is undergoing rapid transformation, fueled by increasing cases of neurological and psychiatric conditions, growing demand for personalized treatments, and a robust drug development pipeline. CNS disorders—which include Alzheimer's disease, Parkinson’s disease, epilepsy, multiple sclerosis, depression, anxiety,...
0 Comments 0 Shares 330 Views 0 Reviews